Mesoblast (ASX:MSB) Institutional Ownership: 15.61% (As of Jul. 05, 2026)


ASX:MSB Mesoblast Ltd ASX:MSB
42 GF Score
Price A$2.06
! 4 Warning Signs
View Full Analysis

What is Mesoblast Institutional Ownership?

Mesoblast ASX:MSB +0.49% 42 Institutional Ownership is 15.61% as of Jul. 05, 2026. GuruFocus rates ASX:MSB with a GF Score™ of 42/100. The stock has 4 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Mesoblast's institutional ownership is 15.61%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Mesoblast's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Mesoblast's Float Percentage Of Total Shares Outstanding is 72.99%.

Mesoblast Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Mesoblast's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mesoblast Institutional Ownership Chart

Mesoblast Historical Data

The historical data trend for Mesoblast can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 14.04 14.20 14.52 14.92 14.97 15.53 15.52 15.53 15.62 15.61
ASX:MSB
42GF Score
Mesoblast Ltd ASX:MSB
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mesoblast Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 15.61% mean?
Mesoblast (ASX:MSB) has a Institutional Ownership of 15.61% as of Jul. 05, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Mesoblast and its competitors.
Is Mesoblast's Institutional Ownership too high?
Mesoblast's current Institutional Ownership is 15.61%. Overall, Mesoblast has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Mesoblast's Institutional Ownership compare to VRTX and REGN?
Mesoblast's Institutional Ownership of 15.61% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Mesoblast and its competitors. Mesoblast's current Institutional Ownership is 15.61%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mesoblast stock overvalued right now?
Mesoblast (ASX:MSB) has a current Institutional Ownership of 15.61%. The current Institutional Ownership is 15.61%. Mesoblast's overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Mesoblast (ASX:MSB), the current Institutional Ownership is 15.61% as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mesoblast Business Description

Address 55 Collins Street, Level 38, Melbourne, VIC, AUS, 3000
Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates include: Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease, as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of an adult stem cell technology platform for commercialization.
42GF Score

Get the complete analysis for ASX:MSB

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.06
Price